The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
The model's full reasoning — Q1 2024 call → NOWe need to determine if management conveys that they have recently finished the heavy phase of a major undertaking and are now in the collecting phase, with results still reflecting the paying phase. Key points from transcript: - Q1 2024 results: production near high end, oil above guidance, capital below guidance. - They raised full-year oil guidance, kept gas guidance. - They delayed some Marcellus turn-in-lines due to low gas prices. - They have two pads of 12 wells completed and waiting to be brought online. - They are making go/no-go decisions monthly. - They are constructive on natural gas long-term. - They mention operational efficiencies, cost savings, record pumping hours, simul-frac crew in Permian, etc. - They mention Windham Row project: 34 wells drilled, simul-frac operations underway, adding 3 Harkey wells. - They mention Marcellus: one rig, reduced frac crew, delaying TILs. - They mention Anadarko: two rigs, one frac crew, large block of completion activity. Question: Does management convey that they have recently finished the expensive, uncertain, or heavy phase of a major undertaking and now entered the collecting phase, with results still reflecting the paying phase? Look for language about completing a major build, development, etc., and that benefits are starting but not yet in numbers. Management talks about operational efficiencies, but not about a specific major undertaking that is now done. They talk about ongoing operations, adjusting activity based on prices. They mention Windham Row project as ongoing, with drilling and simul-frac underway. They mention delaying TILs. They don't say "we have completed the heavy phase" of something. They talk about cost savings and efficiencies, but that's ongoing. They also mention that they have completed wells waiting to be brought online (12 wells). That could be seen as a completed effort (drilling and completion) but they are delaying bringing them online due to prices. So the heavy phase (drilling/completing) is done, but the collecting phase (production) is delayed. However, they are not collecting yet because they are waiting for better prices. So the benefit is not yet arriving; it's contingent on prices. Also, they are not saying that the reported results reflect the paying phase; they are just saying they have wells ready but not turned on.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| CURV | Torrid Holdings Inc. | Q2 2022 | 2022-09-07 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ARCB | ArcBest Corporation | Q4 2016 | 2017-02-08 | C |
IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.